The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.
Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback